Discontinuing treatment with biphosphates after a period of time was associated with a reduction in femoral neck and lumbar spine T-scores, as well as a decrease in bone mineral density among patients ...

May 5, 2005 — Alendronate should not be used to treat postmenopausal women with osteopenia and who are otherwise not at high risk for fracture, according to the results of a cost-effectiveness ...

Background: The effects on bone metabolism of long-term treatment with thyroid hormone given at suppressive doses have been debated. Objective: To determine whether long-term thyroxine therapy in the ...

Purpose: We investigated the bone mineral status in patients with untreated Fabry disease (FD). Methods: Descriptive, cross-sectional study in 53 patients with FD investigating bone mineral density ...

Giving zoledronate every 18 months for 6 years reduced the risk of fragility fractures—both vertebral and nonvertebral—in older women with hip bone mineral density indicating osteopenia, a ...

Please provide your email address to receive an email when new articles are posted on . Patients with psoriatic arthritis did not have a higher prevalence of osteoporosis and bone mineral density was ...

Thin and brittle bones are strongly linked to women’s heart disease risk, with thinning of the lower (lumbar) spine, top of the thigh bone (femoral neck), and hip especially predictive of a heightened ...